Some selloffs are warnings. Others are entry points created by a market that only reads the headline. This company just gave investors both: a cautious full-year outlook and a strong quarter underneath it. The stock is still near its lows, but the business is gaining customers, expanding margins, and building a more recurring pet-care platform.
Tax Strategy (Sponsored)
Many investors overlook deductions that could help minimize capital gains tax, such as:
Eligible investment expenses
Cost basis adjustments
Selling costs tied to property
Each comes with IRS rules and reporting requirements.
That’s why consulting a fiduciary financial advisor is often recommended.
See Advisor Matches.
What Just Happened
The quarter was better than the stock reaction
Chewy, Inc. (NYSE: CHWY) reported fiscal first-quarter 2026 net sales of $3.36 billion, up 7.7% year over year. Gross margin rose 50 basis points to 30.1%, net income increased to $94.8 million, and net margin improved to 2.8%. Adjusted EBITDA reached $253.1 million, with a 7.5% adjusted EBITDA margin.
That is a strong operating update for a stock trading near its 52-week low. The market did not ignore the quarter because the numbers were bad. It ignored the quarter because management trimmed the full-year revenue outlook.
The guide-down hit sentiment
Chewy lowered fiscal 2026 net sales guidance to $13.4 billion to $13.55 billion, down from the prior range of $13.6 billion to $13.75 billion. The company also gave a softer current-quarter outlook than analysts expected. The reason was not a broken model. It was a more cautious pet consumer and softer category demand.
That is the tension in the stock right now. The business is improving operationally, but the category is not giving it a clean demand backdrop.
The recurring revenue engine is still working
Active customers climbed 3.6% year over year to 21.5 million, while net sales per active customer rose 2.4% to $597. Autoship remains the core strength, representing 84.4% of net sales. That is the number that keeps the bull case alive.
Autoship gives Chewy a recurring demand base in a category where customers need repeat purchases. Pets still need food, medication, litter, treats, and healthcare products whether the broader consumer mood is strong or weak.
Why The Business Matters
Chewy is not just an online pet store
Chewy sells pet food, supplies, pharmacy products, insurance-adjacent services, and healthcare-related offerings across the U.S. The core business started as e-commerce, but the long-term strategy is moving toward a broader pet-care ecosystem.
That matters because pet spending has a different profile than many discretionary categories. Customers may trade down, delay extras, or become more price-sensitive, but core pet needs remain durable.
Autoship is the moat
Autoship is the most important part of the story. When more than 80% of sales come through recurring purchase behavior, Chewy has better visibility than a normal online retailer.
This does not eliminate consumer risk. It does make the revenue base stickier. A customer who sets up recurring food, medicine, or supplies is less likely to comparison-shop every order.
Healthcare expands the addressable market
Chewy’s move into veterinary care adds another growth lane. In April, the company agreed to acquire Modern Animal, a veterinary clinic platform that is expected to add more than $125 million in annualized run-rate revenue and expand Chewy Vet Care from 18 to 47 locations nationwide. The deal is expected to be EBITDA-dollar neutral in 2026, with contribution beginning in 2027.
That gives Chewy a bigger role in the full pet-care wallet. The company is not just trying to sell more bags of food. It is trying to connect commerce, pharmacy, and healthcare.
Which market cap category do you think offers the best risk/reward right now?
Market Signal (Sponsored)
No one believed Whitney Tilson when he predicted the collapse of Bear Stearns and Lehman Brothers. Or when he went on 60 Minutes exposing a company poisoning its own customers. (The stock fell nearly 80%.)
Now he has a new warning about what's REALLY around the corner for America's most beloved tech companies.
Watch for free here.
Why The Stock Has A Case
Profitability is moving in the right direction
Chewy’s revenue growth was solid, but the better part was margin expansion. Gross margin improved, net margin improved, adjusted EBITDA margin reached 7.5%, and free cash flow came in at $70.8 million.
That matters because the old knock on Chewy was that online pet retail would struggle to generate real profits. The latest quarter pushes back against that view. The model is scaling.
The stock has already reset hard
CHWY is down sharply over the past year and trades far below its 52-week high. That gives the stock a different setup than a fully priced growth name. Investors are not paying for perfection here. They are buying a business that still grows high single digits while the market worries about the consumer.
That is why the guidance cut may be an opportunity rather than a thesis-breaker. The numbers were reset lower. The margin story stayed intact.
The valuation is reasonable if growth stabilizes
CHWY trades around 0.6 times expected fiscal 2026 sales using the current market cap and management’s revenue guidance range. That is not aggressive for a scaled e-commerce platform with high recurring sales, expanding margins, and a healthcare expansion path.
The P/E ratio looks less cheap because net margins are still thin. But if EBITDA margins keep expanding, the stock does not need massive revenue acceleration to work.
Elite Trade Club Insider
$160 Million In Insider Supply Just Hit Two Market Winners
You’re seeing two charts after the easy money already showed up. One has exploded more than 550% in a year, while the other is sitting near a 52-week high after a 56% run. But Elite Trade Club Insider readers are getting the sharper read: big holders and insiders are not waiting around for the crowd to catch up — they are using this strength to cash out while the charts still look hot.
You’re reading the free version. Here’s what we held back.
Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.
A subscription gets you:
The insider buys, options bets, and dark pool moves the free edition can't show you. Unlocked every weekday.
A Sunday Deep Dive that tells you where to look before Monday's bell rings.
The Friday Smart Money Brief: who bought, who sold, where the big options bets landed, and where institutions are hiding volume. Three data layers. One email.
A Monthly Insider Scorecard so you always know whether smart money is buying or selling the market.
Every past Insider edition, unlocked, on elitetrade.club. Go back and see what you missed.
$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.
What Has To Go Right
The pet consumer needs to stabilize
This is the first test. Management lowered revenue guidance because demand softened. Chewy needs to show that the category is slowing, not breaking.
Autoship needs to stay strong
Autoship penetration at 84.4% is a major advantage. If that number holds or improves, investors will keep giving Chewy credit for recurring revenue quality.
Healthcare needs to become more than a side project
Modern Animal gives Chewy scale in vet care, but the company needs to prove clinics can generate attractive returns and create cross-selling benefits across pharmacy, commerce, and wellness.
Global Focus (Sponsored)
When DeepSeek hit the headlines, Nvidia dropped nearly $600 billion in a single session.
Every investor felt it: What if China just won the AI race? But behind closed doors, America has already fired back — with a hidden project at the same Tennessee lab that built the atom bomb. 40,000 scientists. A device trillions of times more powerful than anything China has built.
A $100 trillion AI reset on the way. Billion-dollar money manager Louis Navellier has identified the one stock that wins this arms race.
Click here for the name and ticker — free.
*This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.
What Could Trip It Up
Guidance could get cut again
The market will not be patient with another reset. If pet spending weakens further or management trims the outlook again, the stock can stay stuck near its lows.
Margins are still thin
Net margin improved to 2.8%, but this is still a low-margin business. Fuel costs, fulfillment costs, promotions, and weaker category demand can pressure profitability quickly.
The balance sheet needs watching
Chewy’s working-capital profile is not as comfortable as a traditional cash-heavy retailer. The business has strong cash conversion, but investors should still watch liquidity, inventory, and fulfillment efficiency if the consumer weakens further.
What I’d Watch Next
The first thing to watch is active customer growth. Chewy added customers in Q1, and that trend needs to continue. The second is Autoship penetration, because recurring revenue is the heart of the bull case. The third is adjusted EBITDA margin. Management maintained its fiscal 2026 adjusted EBITDA margin outlook at 6.6% to 6.8%, even after lowering sales guidance. That is important.
The fourth is Modern Animal integration. If the healthcare push starts showing evidence of stronger customer value and better retention, the market will view Chewy as more than an online retailer.
My Take
Buy at current levels. Chewy is dealing with a softer pet consumer, but the business is not broken. Revenue still grew 7.7%, active customers increased, Autoship is now more than 84% of sales, margins expanded, and free cash flow improved. The stock has already been punished enough that investors can buy the recovery without paying a premium multiple.
The key risk is another guidance cut. If pet spending weakens further, the stock will remain under pressure. But if demand stabilizes and margins keep improving, CHWY can re-rate back toward the mid-$20s and eventually the low-$30s.
Action Recap
🐶 Looking to buy? Buy at current levels for a recovery setup backed by Autoship, margin expansion, and pet-healthcare optionality.
📦 Already own it? Keep holding while customer growth, Autoship penetration, and EBITDA margins stay intact.
⚠️ Main risk to respect: A second guidance cut would hurt. The bull case needs pet demand to stabilize over the next few quarters.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
